SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-126869
Filing Date
2023-12-18
Accepted
2023-12-18 16:15:16
Documents
14
Period of Report
2023-12-14
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2333000d1_8k.htm   iXBRL 8-K 34094
2 EXHIBIT 16.1 tm2333000d1_ex16-1.htm EX-16.1 3662
3 GRAPHIC tm2333000d1_ex16-1img001.jpg GRAPHIC 2967
  Complete submission text file 0001104659-23-126869.txt   218554

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vrna-20231214.xsd EX-101.SCH 3027
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrna-20231214_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrna-20231214_pre.xml EX-101.PRE 22367
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2333000d1_8k_htm.xml XML 3321
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38067 | Film No.: 231493893
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)